Target intelligence / Profile preview

MicroRNA 4273 (MIR4273)

Target
MIR4273
Molecular classification
Non-coding RNA, MicroRNA
01

Overview

MicroRNA 4273 (MIR4273, also known as hsa-mir-4273 or miR-4273-5p) is a small, non-coding RNA molecule identified in humans. It belongs to the microRNA (miRNA) family, which regulates gene expression by binding to target mRNAs, usually resulting in translational repression or degradation. MIR4273 has been studied in the context of cancer, particularly colorectal cancer, where it specifically interacts with the A allele of the rs7930 SNP in the 3′ untranslated region of the TOMM20 gene, leading to reduced TOMM20 expression. The G allele at rs7930 does not interact with MIR4273 and has been associated with an increased risk of colorectal cancer. MIR4273 currently serves as a component of genetic risk biomarkers rather than a direct therapeutic target.

Other names
hsa-mir-4273miR-4273miR-4273-5pMIR4273
02

Mechanism of action

MIR4273 acts by binding to specific mRNA sequences (e.g., at SNP sites such as rs7930 in the 3′UTR of TOMM20), resulting in suppression of target gene expression at the post-transcriptional level

03

Biological functions

Regulation of gene expression (post-transcriptional silencing)Modulation of mRNA stability and translationPotential involvement in regulation of cell proliferation and cell cycle, particularly in the context of cancer
04

Disease associations

Cancer (specifically implicated in colorectal cancer via regulation of TOMM20 through allele-specific interaction at rs7930)Other (possible wider roles typical of microRNAs as tumor suppressors or oncogenes)
05

Biomarkers

The interaction between the miR-4273-5p and the rs7930 A allele has been proposed as a diagnostic biomarker for colorectal cancer risk

Beyond the preview

Go deeper on MicroRNA 4273 (MIR4273).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4273 (MIR4273).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call